Thermo Fisher to Sell Microbiology Business to Astorg in USD 1.07 Billion Deal
Thermo Fisher’s microbiology business, which generated USD 645 million in 2025 revenue, will transition to Astorg as part of a strategic portfolio realignment.
Antimicrobial Testing | 29/04/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy